
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion.
Alexandra Freeman from the Winton Centre for Risk and Evidence Communication joins the Drug Safety Matters podcast to discuss how to give patients the information they need to decide what's best for them. This fascinating episode challenges assumptions about the role of the narratives in health communication and provides practical, evidence-backed guidance for conveying effective, ethical information about the potential harms and benefits of medicines and vaccines.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
To celebrate #MedSafetyWeek, Drug Safety Matters presents a two-part episode on medicine safety communication campaigns and how they help us spread the pharmacovigilance message.
Communications / 14 November 2023
As well as promoting PV research and training in Europe, the chapter aims to foster communication and collaboration between European institutions working in drug safety.
Communications / 28 June 2023
To celebrate #MedSafetyWeek, Drug Safety Matters presents a two-part episode on medicine safety communication campaigns and how they help us spread the pharmacovigilance message.
Communications / 06 November 2023